British Journal of Biomedical Science最新文献

{"title":"SPHINX-Based Combination Therapy as a Potential Novel Treatment Strategy for Acute Myeloid Leukaemia.","authors":"Chigeru Wodi,&nbsp;Tareg Belali,&nbsp;Ruth Morse,&nbsp;Sean Porazinski,&nbsp;Michael Ladomery","doi":"10.3389/bjbs.2023.11041","DOIUrl":"https://doi.org/10.3389/bjbs.2023.11041","url":null,"abstract":"<p><p><b>Introduction:</b> Dysregulated alternative splicing is a prominent feature of cancer. The inhibition and knockdown of the SR splice factor kinase SRPK1 reduces tumour growth <i>in vivo</i>. As a result several SPRK1 inhibitors are in development including SPHINX, a 3-(trifluoromethyl)anilide scaffold. The objective of this study was to treat two leukaemic cell lines with SPHINX in combination with the established cancer drugs azacitidine and imatinib. <b>Materials and Methods:</b> We selected two representative cell lines; Kasumi-1, acute myeloid leukaemia, and K562, BCR-ABL positive chronic myeloid leukaemia. Cells were treated with SPHINX concentrations up to 10μM, and in combination with azacitidine (up to 1.5 μg/ml, Kasumi-1 cells) and imatinib (up to 20 μg/ml, K562 cells). Cell viability was determined by counting the proportion of live cells and those undergoing apoptosis through the detection of activated caspase 3/7. SRPK1 was knocked down with siRNA to confirm SPHINX results. <b>Results:</b> The effects of SPHINX were first confirmed by observing reduced levels of phosphorylated SR proteins. SPHINX significantly reduced cell viability and increased apoptosis in Kasumi-1 cells, but less prominently in K562 cells. Knockdown of SRPK1 by RNA interference similarly reduced cell viability. Combining SPHINX with azacitidine augmented the effect of azacitidine in Kasumi-1 cells. In conclusion, SPHINX reduces cell viability and increases apoptosis in the acute myeloid leukaemia cell line Kasumi-1, but less convincingly in the chronic myeloid leukaemia cell line K562. <b>Conclusion:</b> We suggest that specific types of leukaemia may present an opportunity for the development of SRPK1-targeted therapies to be used in combination with established chemotherapeutic drugs.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988938/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9178494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changes in Mitochondrial Epigenome in Type 2 Diabetes Mellitus.","authors":"Hui Ching Low,&nbsp;William M Chilian,&nbsp;Wickneswari Ratnam,&nbsp;Tilakavati Karupaiah,&nbsp;Mohd Fairulnizal Md Noh,&nbsp;Fazliana Mansor,&nbsp;Zhi Xiang Ng,&nbsp;Yuh Fen Pung","doi":"10.3389/bjbs.2023.10884","DOIUrl":"https://doi.org/10.3389/bjbs.2023.10884","url":null,"abstract":"<p><p>Type 2 Diabetes Mellitus is a major chronic metabolic disorder in public health. Due to mitochondria's indispensable role in the body, its dysfunction has been implicated in the development and progression of multiple diseases, including Type 2 Diabetes mellitus. Thus, factors that can regulate mitochondrial function, like mtDNA methylation, are of significant interest in managing T2DM. In this paper, the overview of epigenetics and the mechanism of nuclear and mitochondrial DNA methylation were briefly discussed, followed by other mitochondrial epigenetics. Subsequently, the association between mtDNA methylation with T2DM and the challenges of mtDNA methylation studies were also reviewed. This review will aid in understanding the impact of mtDNA methylation on T2DM and future advancements in T2DM treatment.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9393294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antimicrobial Resistance (AMR).","authors":"Ka Wah Kelly Tang,&nbsp;Beverley C Millar,&nbsp;John E Moore","doi":"10.3389/bjbs.2023.11387","DOIUrl":"https://doi.org/10.3389/bjbs.2023.11387","url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) has now emerged as a chronic public health problem globally, with the forecast of 10 million deaths per year globally by 2050. AMR occurs when viruses, bacteria, fungi and parasites do not respond to antimicrobial treatments in humans and animals, thus allowing the survival of the microorganism within the host. The prominent cause contributing to the current crisis remains to be the overuse and misuse of antimicrobials, particularly the inappropriate usage of antibiotics, increasing the global burden of antimicrobial resistance. The global consumption and usage of antibiotics are therefore closely monitored at all times. This review provides a current overview of the implications of strategies used by international governmental organisations, including the UN's 17 Sustainable Development Goals (SDGs), to address the problem of antibiotic resistance, as well as the \"<i>One Health Approach</i>,\" a system incorporating a multidisciplinary effort to achieve the best possible health outcome by acknowledging the clear connections between humans, animals and their shared environment. The importance of public awareness and health literacy of lay audiences still needs to be further emphasised as part of global and local action plans. Antimicrobial resistance continues to be a major global public health dilemma of the 21st century. Already this topic is receiving substantial political input from the G7 countries and continues to be on the agenda of numerous political conferences. The consequences of failure to adequately address AMR are profound, with estimations of a return to the pre-antibiotic era, where everyday infections relating to childbirth, surgery and open fractured limbs could be potentially life-threatening. AMR itself represents a microcosm of factors, including social anthropology, civil unrest/war, diasporas, ethnic displacement, political systems, healthcare, economics, societal behaviour both at a population and individual level, health literacy, geoclimatic events, global travel and pharmaceutical innovation and investment, thus finding a solution that adequately addresses AMR and which helps stem further AMR emergence is complicated. Success will involve individuals, communities and nations all working together to ensure that the world continues to possess a sufficient armamentarium of effective antimicrobials that will sustain human and animal health, both now and in the future.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10199042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic Role of CD68⁺ and CD163⁺ Tumour-Associated Macrophages and PD-L1 Expression in Oral Squamous Cell Carcinoma: A Meta-Analysis.","authors":"Mohammed Haseeb Chohan,&nbsp;Matthew Perry,&nbsp;Paul Laurance-Young,&nbsp;Vehid M Salih,&nbsp;Andrew D Foey","doi":"10.3389/bjbs.2023.11065","DOIUrl":"https://doi.org/10.3389/bjbs.2023.11065","url":null,"abstract":"<p><p><b>Background:</b> Oral squamous cell carcinoma (OSCC) is a common malignant cancer in humans. An abundance of tumour associated macrophages (TAMs) create an immunosuppressive tumour microenvironment (TME). TAM markers (CD163 and CD68) are seen to serve as prognostic factors in OSCC. PD-L1 has seen to widely modulate the TME but its prognostic significance remains controversial. The aim of this meta-analysis is to evaluate the prognostic role of CD163⁺, CD68⁺ TAMs and PD-L1 in OSCC patients. <b>Methods:</b> Searches in PubMed, Scopus and Web of Science were performed; 12 studies were included in this meta-analysis. Quality assessment of included studies was performed according to REMARK guidelines. Risk of bias across studies was investigated according to the rate of heterogeneity. Meta-analysis was performed to investigate the association of all three biomarkers with overall survival (OS). <b>Results:</b> High expression of CD163⁺ TAMs were associated with poor overall survival (HR = 2.64; 95% Cl: [1.65, 4.23]; <i>p</i> < 0.0001). Additionally, high stromal expression of CD163⁺ TAMs correlated with poor overall survival (HR = 3.56; 95% Cl: [2.33, 5.44]; <i>p</i> < 0.00001). Conversely, high CD68 and PD-L1 expression was not associated with overall survival (HR = 1.26; 95% Cl: [0.76, 2.07]; <i>p</i> = 0.37) (HR = 0.64; 95% Cl: [0.35, 1.18]; <i>p</i> = 0.15). <b>Conclusion:</b> In conclusion, our findings indicate CD163⁺ can provide prognostic utility in OSCC. However, our data suggests CD68⁺ TAMs were not associated with any prognostic relevance in OSCC patients, whereas PD-L1 expression may prove to be a differential prognostic marker dependent on tumour location and stage of progression.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10143762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"<i>Faecalibacterium prausnitzii</i> Improves Lipid Metabolism Disorder and Insulin Resistance in Type 2 Diabetic Mice.","authors":"Wenting Xuan,&nbsp;Yijing Ou,&nbsp;Wenting Chen,&nbsp;Lishan Huang,&nbsp;Chuangyu Wen,&nbsp;Guangying Huang,&nbsp;Wenting Tang,&nbsp;Daidi Zeng,&nbsp;Suran Huang,&nbsp;Lijuan Xiao,&nbsp;Zhongjun Li","doi":"10.3389/bjbs.2023.10794","DOIUrl":"https://doi.org/10.3389/bjbs.2023.10794","url":null,"abstract":"<p><p><b>Purpose:</b> Additional effective therapeutic strategies for Type 2 diabetes (T2D) patients are urgently needed<i>.</i> Gut microbiota plays an important role in T2D development and is a promising treatment strategy for T2D patients. Faecalibacterium prausnitzii (<i>F. prausnitzii</i>) is regarded as one of the most important bacterial indicators for a healthy gut, but the mechanisms of its anti-diabetic properties are still unclear. <b>Methods and Results:</b> The abundance of <i>F. prausnitzii</i> in feces of patients with T2D was detected by using qPCR. The effects of <i>F. prausnitzii</i> on glucose homeostasis, insulin resistance (IR), dyslipidemia, hepatic steatosis and inflammation were investigated in type 2 diabetic (T2D) db/db mice. We also investigated <i>F. prausnitzii</i> in people. Our results showed that the abundance of <i>F. prausnitzii</i> was significantly lower in T2D patients compared to healthy subjects. In T2D mice, we found that <i>F. prausnitzii</i> treatment significantly decreased fasting blood glucose and IR index, indicating improved glucose intolerance as well as IR. Furthermore, based on evaluation of lipid-regulating enzyme activities and proinflammatory cytokine levels, <i>F. prausnitzii</i> was not only able to improve inflammation in both adipose tissue and liver, but also ameliorate hepatic steatosis through inhibiting the activity of hepatic lipogenic enzymes. <b>Conclusion:</b> These results suggested that <i>F. prausnitzii</i> might serve as a therapeutic option for T2D by improved IR, lipid metabolism and inflammation.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070466/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9271374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer.","authors":"Xiew Leng Liau,&nbsp;Shamala Salvamani,&nbsp;Baskaran Gunasekaran,&nbsp;Dinesh Kumar Chellappan,&nbsp;Anthony Rhodes,&nbsp;Vaidehi Ulaganathan,&nbsp;Yee Lian Tiong","doi":"10.3389/bjbs.2023.11103","DOIUrl":"https://doi.org/10.3389/bjbs.2023.11103","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is ranked as the third most common cancer and second deadliest cancer in both men and women in the world. Currently, the cure rate and 5-year survival rate of CRC patients remain relatively low. Therefore, discovering a novel molecular biomarker that can be used to improve CRC screening, diagnosis, prognosis, and treatment would be beneficial. Long non-coding RNA colon cancer-associated transcript 1 (CCAT 1) has been found overexpressed in CRC and is associated with CRC tumorigenesis and treatment outcome. CCAT 1 has a high degree of specificity and sensitivity, it is readily detected in CRC tissues and is significantly overexpressed in both premalignant and malignant CRC tissues. Besides, CCAT 1 is associated with clinical manifestation and advanced features of CRC, such as lymph node metastasis, high tumor node metastasis stage, differentiation, invasion, and distant metastasis. In addition, they can upregulate oncogenic c-MYC and negatively modulate microRNAs <i>via</i> different mechanisms of action. Furthermore, dysregulated CCAT 1 also enhances the chemoresistance in CRC cells while downregulation of them reverses the malignant phenotypes of cancer cells. In brief, CCAT 1 serves as a potential screening, diagnostic and prognostic biomarker in CRC, it also serves as a potential therapeutic marker to treat CRC patients.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9276695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Relevance of HLA-DP/DQ and INF-λ4 Polymorphisms to COVID-19 Outcomes.","authors":"Amany A Ghazy,&nbsp;Abdullah N Alrasheedi,&nbsp;Mohammed Elashri,&nbsp;Hany Hussein Moussa,&nbsp;Eman K Rashwan,&nbsp;Ibrahim Amer,&nbsp;Shimaa El Sharawy,&nbsp;Shimaa Elgamal,&nbsp;Salwa Tawfik,&nbsp;Mohamed Abdelnasser,&nbsp;Amel Elsheredy","doi":"10.3389/bjbs.2023.11044","DOIUrl":"https://doi.org/10.3389/bjbs.2023.11044","url":null,"abstract":"<p><p><b>Background:</b> Single nucleotide polymorphisms provide information on individuals' potential reactions to environmental factors, infections, diseases, as well as various therapies. A study on SNPs that influence SARS-CoV-2 susceptibility and severity may provide a predictive tool for COVID-19 outcomes and improve the customized coronavirus treatment. <b>Aim:</b> To evaluate the role of human leukocyte antigens DP/DQ and IFNλ4 polymorphisms on COVID-19 outcomes among Egyptian patients. <b>Participants and Methods:</b> The study involved 80 patients with severe COVID-19, 80 patients with mild COVID-19, and 80 non-infected healthy volunteers. Genotyping and allelic discrimination of HLA-DPrs3077 (G/A), HLA-DQrs7453920 (A/G), and IFNλ4 rs73555604 (C/T) SNPs were performed using real-time PCR. <b>Results:</b> Ages were 47.9 ± 8, 44.1 ± 12.1, and 45.8 ± 10 years in severe, mild and non-infected persons. There was a statistically significant association between severe COVID-19 and male gender (<i>p</i> = 0.002). A statistically significant increase in the frequency of HLA-DPrs3077G, HLA-DQrs7453920A, and IFNλ4rs73555604C alleles among severe COVID-19 patients when compared with other groups (<i>p</i> < 0.001). Coexistence of these alleles in the same individual increases the susceptibility to severe COVID-19 by many folds (<i>p</i> < 0.001). Univariate and multivariate logistic regression analysis for the studied parameters showed that old age, male gender, non-vaccination, HLA-DQ rs7453920AG+AA, HLA-DPrs3077GA+GG, and IFNλ4rs73555604CT+CC genotypes are independent risk factors for severe COVID-19 among Egyptian patients. <b>Conclusion</b>: HLA-DQ rs7453920A, HLA-DPrs3077G, and IFNλ4rs73555604C alleles could be used as markers of COVID-19 severity.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9236831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changing Molecular Profiles of Human Cryptosporidiosis Cases in Scotland as a Result of the Coronavirus Disease, COVID-19 Pandemic.","authors":"Ross Bacchetti,&nbsp;Lisa Connelly,&nbsp;Lynda Browning,&nbsp;Claire L Alexander","doi":"10.3389/bjbs.2023.11462","DOIUrl":"https://doi.org/10.3389/bjbs.2023.11462","url":null,"abstract":"<p><p><i>Cryptosporidium</i>, the most frequently reported parasite in Scotland, causes gastrointestinal illness resulting in diarrhoea, nausea and cramps. Two species are responsible for most cases: <i>Cryptosporidium hominis (C. hominis)</i> and <i>Cryptosporidium parvum</i> (<i>C. parvum</i>). Transmission occurs faecal-orally, through ingestion of contaminated food and water, or direct contact with faeces. In 2020, the COVID-19 pandemic led to global restrictions, including national lockdowns to limit viral transmission. Such interventions led to decreased social mixing, and reduced/no local and international travel, which are factors associated with transmission of multiple communicable diseases, including cryptosporidiosis. This report assessed the impact of the pandemic on Scottish cryptosporidiosis cases, and identified changes in circulating molecular variants of <i>Cryptosporidium</i> species. Molecular data generated using real time PCR and GP60 nested-PCR assays on laboratory-confirmed cryptosporidiosis cases reported during 2018-22 were analysed. The Scottish Microbiology Reference Laboratories (SMiRL), Glasgow, received 774 <i>Cryptosporidium</i>-positive faeces during 2018-22, of which 486 samples were successfully subtyped. During this time period, <i>C. hominis</i> (<i>n</i> = 155; 21%) and <i>C. parvum</i> (<i>n</i> = 572; 77%) were the most commonly detected species. The total number of cases during 2020, which was greatly affected by the pandemic, was markedly lower in comparison to case numbers in the 2 years before and after 2020. The most predominant <i>C. hominis</i> family detected prior to 2020 was the Ib family which shifted to the Ie family during 2022. The most common <i>C. parvum</i> variant during 2018-22 was the IIa family, however a rise in the IId family was observed (<i>n</i> = 6 in 2018 to <i>n</i> = 25 in 2022). The dominant <i>C. hominis</i> subtype IbA10G2, which accounted for 71% of <i>C. hominis</i> subtypes in 2018-19 was superseded by three rare subtypes: IeA11G3T3 (<i>n</i> = 15), IdA16 (<i>n</i> = 8) and IbA9G3 (<i>n</i> = 3) by 2022. Frequently reported <i>C. parvum</i> subtypes in 2018-19 were IIaA15G2R1 and IIaA17G1R1, accounting for 59% of total <i>C. parvum</i> subtypes. By 2022, IIaA15G2R1 remained the most common (<i>n</i> = 28), however three unusual subtypes in Scotland emerged: IIdA24G1 (<i>n</i> = 7), IIaA16G3R1 (<i>n</i> = 7) and IIaA15G1R2 (<i>n</i> = 7). Continuous monitoring of <i>Cryptosporidium</i> variants following the pandemic will be essential to explore further changes and emergence of strains with altered virulence.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10244476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SARS-CoV-2 and COVID-19: A Narrative Review.","authors":"A D Blann, R Heitmar","doi":"10.3389/bjbs.2022.10426","DOIUrl":"10.3389/bjbs.2022.10426","url":null,"abstract":"<p><p>The World Health Organisation has reported that the viral disease known as COVID-19, caused by SARS-CoV-2, is the leading cause of death by a single infectious agent. This narrative review examines certain components of the pandemic: its origins, early clinical data, global and UK-focussed epidemiology, vaccination, variants, and long COVID.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33477632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long Non-Coding RNA LINC01929 Facilitates Cell Proliferation and Metastasis as a Competing Endogenous RNA Against MicroRNA miR-1179 in Non-Small Cell Lung Carcinoma.","authors":"Tinghong Pan,&nbsp;Hui Wang,&nbsp;Shuai Wang,&nbsp;Feng Liu","doi":"10.3389/bjbs.2022.10598","DOIUrl":"https://doi.org/10.3389/bjbs.2022.10598","url":null,"abstract":"<p><p><b>Introduction:</b> Non-small cell lung carcinoma (NSCLC) constitutes most lung cancers and has a poor prognosis. LncRNAs are a potential repository for the discovery of cancer prognostic markers. This study explored the role of LINC01929 in NSCLC, both the clinical prognostic significance and the mechanism of its influence on cells. <b>Materials and Methods:</b> LINC01929 levels in 143 pairs of NSCLC tissues and non-cancerous tissues were detected by RT-qPCR. Kaplan-Meier curves and multivariate Cox regression assays were generated for evaluating the prognostic values of LINC01929. To evaluate the cellular function, an XTT assay and transwell invasion assays were performed. <b>Results:</b> LINC01929 was up-regulated in NSCLC tissues compared with healthy tissues. A positive correlation was observed between LINC01929 expression level and tumor T (<i>p</i> = 0.002) or N stage (<i>p</i> = 0.010). Patients with higher LINC01929 levels had shorter overall survival (<i>p</i> = 0.009). Compared with other factors, high LINC01929 expression was significantly associated with poor survival in univariate Cox analysis (HR: 2.485, 95%CI: 1.220-5.060, <i>p</i> = 0.012). After multivariate Cox regression assays, LINC01929 was a independent prognostic factor (HR: 3.021, 95%CI: 1.377-6.628, <i>p</i> = 0.006). miR-1179 was a target miRNA of LINC01929. Inhibited expression of LINC01929 significantly reduced the proliferation, migration, and invasion of NSCLC cells by targeting miR-1179. <b>Discussion:</b> This study revealed the upregulation of LINC01929 in NSCLC. This study supports previous studies showing LINC01929 as a potential prognostic factor for NSCLC.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2022-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329516/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40412133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}